S1 E6 - Dr Chetan Deshmukh – ESMO 2022 – The Latest Updates in Colorectal Cancer

Karger - Fast Facts Oncology

Welcome to the first episode in a three-part special live from ESMO 2022. In this episode focused on colorectal cancer, we speak with Dr Chetan Deshmukh, a practicing medical oncologist from Pune, India. Dr Deshmukh discusses the results from the CARIO5 study, which have been presented at the congress. He also shares with us his thoughts on the promise of novel immunotherapeutics and targeted therapies in CRC management and provides his perspective on disparities in drug access in low-middle income countries.

For additional coverage and conference highlights in Oncology please visit https://www.karger.com/SubjectArea/Oncology/oncology-conference-highlights

For more podcast episodes from Karger please visit https://www.karger.com/podcasts

This podcast episode has been made possible by the contribution from Mylan Pharmaceuticals Private Limited, a Viatris Company. Viatris did not have any influence on the content and all items were subject to independent editorial review. These contents should not be construed to be medical, or consulting advice. The viewers assume all risk for use of the information and the content provided in the podcast episode. In no event shall Mylan Pharmaceuticals Private Limited or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages of any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has been informed of the possibility in advance, resulting from or in connection with the creation or use of or reliance in the podcast episode.